Abstract

In this article, the four coordinators of neglected tropical disease (NTD) drug development projects funded under the European Commission (EC) Framework Programme 7 argue that the EC should reassess their funding strategy to cover the steps necessary to translate a lead compound into a drug candidate for testing in clinical trials, and suggest ways in which this might be achieved.

Highlights

  • Dobrowolski, J.M. et al (1997) Actin in the parasite Toxoplasma gondii is encoded by a single copy gene, ACT1, and exists primarily in a globular form

  • J. et al (2017) Toxoplasma gondii F-actin forms an extensive filamentous network required for material exchange and parasite maturation

  • The four coordinators of neglected tropical disease (NTD) drug development projects funded under the European Commission (EC) Framework Programme 7 argue that the EC should reassess their funding strategy to cover the steps necessary to translate a lead compound into a drug candidate for testing in clinical trials, and suggest ways in which this might be achieved

Read more

Summary

Introduction

The four coordinators of neglected tropical disease (NTD) drug development projects funded under the European Commission (EC) Framework Programme 7 argue that the EC should reassess their funding strategy to cover the steps necessary to translate a lead compound into a drug candidate for testing in clinical trials, and suggest ways in which this might be achieved. EC Funding of NTD Drug Development The EC has consistently and substantially supported research into NTDs, starting well before the London Declaration of 2012 (http://unitingtocombatntds.org/ resource/london-declaration), which put the control or elimination of NTDs at the forefront of global efforts to ‘chart a new course toward health and sustainability among the world’s poorest communities to a stronger, healthier future’.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call